Section 232

2 articles

Monster Beverage disclosed that can costs are rising due to elevated Midwest aluminum premiums driven by Section 232 tariffs on imported aluminum; the company is implementing mitigation strategies to keep impacts at "modest" levels.
Supply Chain

Monster Expects "Modest Impact" From Rising Aluminum Tariffs

Monster Expects "Modest Impact" From Rising Aluminum Tariffs
The US–EU pharmaceutical tariff agreement reached last summer imposes a 15% tax on medicines imported from Europe and provides Section 232 exemptions for certain products. In the short term, it is expected to raise drug prices and insurance premiums; in the long term, it may trigger a restructuring of the supply chain.
Supply Chain

Will US–EU Pharma Tariffs Restore Domestic Production?

Will US–EU Pharma Tariffs Restore Domestic Production?